University of Osaka researchers used genome editing to program mouse liver cells to produce exenatide, a weight-loss drug.

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Researchers create a one-time genome editing introducing a GLP-1 receptor agonist, resulting in long-term appetite ...

Weight-loss drugs have surged in popularity, promising rapid results with regular injections. Now, researchers from Japan report a way ...

Adults with type 1 diabetes on multiple daily injection therapy saw no benefit in glycemic measures when adding on preprandial injections of short-acting exenatide, according to findings from a ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...